导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 38.68% | 108/1050 |
| 近一周 | -2.82% | 891/1104 |
| 近一月 | -7.81% | 987/1103 |
| 近一季 | -2.76% | 385/1092 |
| 近半年 | 21.54% | 149/1070 |
| 近一年 | 51.60% | 79/1018 |
| 近两年 | 151.85% | 106/926 |
| 近三年 | 91.31% | 111/834 |
| 成立以来 | 139.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
7.39% 81/1070 |
58.25% 187/1101 |
- - |
- - |
| 2025 | 42.32% 291/1065 |
2.90% 552/1014 |
1.70% 537/1038 |
37.73% 234/1050 |
-1.26% 514/1065 |
| 2024 | 1.71% 532/1011 |
-6.65% 645/960 |
-5.29% 647/983 |
14.81% 247/991 |
0.20% 309/1011 |
| 2023 | -12.48% 415/952 |
6.54% 237/880 |
-3.21% 394/895 |
-11.40% 645/915 |
-4.20% 422/952 |
| 2022 | -28.30% 585/867 |
-20.13% 522/773 |
12.44% 178/806 |
-15.37% 588/845 |
-5.66% 663/867 |
| 2021 | 24.93% 112/740 |
-3.92% 302/580 |
20.13% 162/659 |
5.21% 124/704 |
2.88% 310/740 |
| 2020 | 78.09% 99/554 |
3.73% 86/419 |
33.58% 84/466 |
9.94% 254/517 |
16.90% 170/554 |
| 2019 | 66.40% 50/410 |
29.62% 391/1149 |
-2.46% 549/1231 |
12.34% 73/390 |
17.15% 30/410 |
| 2018 | -31.44% 239/349 |
- - |
- - |
- - |
-12.90% 717/1080 |
| 2017 | 14.79% 111/285 |
- - |
- - |
- - |
- - |
| 2016 | -8.70% 66/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 嘉实先进制造股票 VS. 东吴新产业精选股票A(580008) |